Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    

ARENA PHARMACEUTICALS, INC.
Mes dernières consult.
Most popular
Report
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about ARENA PHARMACEUTICALS, INC
10:55a ARENA PHARMACEUTICALS : Announces Late Breaking Presentation of Positive Phase 2..
10/19 ARENA PHARMACEUTICALS : Announces Late Breaking Presentation of Positive Phase 2..
09/08 ARENA PHARMACEUTICALS : to Present Additional Pre Clinical Data on Ralinepag for..
09/06 ARENA PHARMACEUTICALS : to Present Additional Pre-Clinical Data on Ralinepag for..
08/29 ARENA PHARMACEUTICALS : to Participate in Upcoming Investor Conferences
08/23 ARENA PHARMACEUTICALS : to Present Additional Pre Clinical Data on Ralinepag for..
08/22 ARENA PHARMACEUTICALS : to Present Additional Pre-Clinical Data on Ralinepag for..
08/08 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) reported earnings of ($0.77) per sha..
08/07 ARENA PHARMACEUTICALS : reports 2Q loss
08/07 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) Files An 8-K Results of Operations a..
08/07 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Second Quarter 201..
07/31 ARENA PHARMACEUTICALS : to Release Second Quarter 2017 Financial Results and Pro..
07/31 ARENA PHARMACEUTICALS : Announces Full Exercise of Underwriters' Option to Purch..
07/13 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) Files An 8-K Other Events
07/13 ARENA PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
10:55a ARENA PHARMACEUTICALS : Announces Late Breaking Presentation of Positive Phase 2..
10/19 ARENA PHARMACEUTICALS : Announces Late Breaking Presentation of Positive Phase 2..
09/08 ARENA PHARMACEUTICALS : to Present Additional Pre Clinical Data on Ralinepag for..
09/06 ARENA PHARMACEUTICALS : to Present Additional Pre-Clinical Data on Ralinepag for..
08/31 ARENA PHARMACEUTICALS : to Present Additional Pre-Clinical Data on Ralinepag for..
08/29 ARENA PHARMACEUTICALS : to Participate in Upcoming Investor Conferences
08/23 ARENA PHARMACEUTICALS : to Present Additional Pre Clinical Data on Ralinepag for..
08/22 ARENA PHARMACEUTICALS : to Present Additional Pre-Clinical Data on Ralinepag for..
08/10 ARENA PHARMACEUTICALS : Announces Full Exercise of Underwriters' Option to Purch..
08/09 ARENA PHARMACEUTICALS : Reports Q2 Loss, Updates Pipeline Status
More news
Sector news : Biotechnology & Medical Research - NEC
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval -- Update
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval
10/18DJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
10/17DJJOHNSON & JOHNSON : Raises Guidance on Earnings Beat
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
06/22 Arena Pharmaceuticals (ARNA) Presents At JMP Securities Life Sciences Confere..
06/21 Arena Pharmaceuticals' (ARNA) CEO Amit Munshi Presents at JMP Securities Life..
06/20 Arena continues up move, shares ahead 25% in three days
06/19 DRYSHIPS : Rank #1 As Worst Stock In Nasdaq
06/17 Stocks to watch next week
06/15 PREMARKET LOSERS AS OF 9 : 05 am
Latest Tweets
10/19Arena Pharmaceuticals Announces Late Breaking Presentation of Positive Phase .. 
10/19$ARNA Arena Pharmaceuticals Announces Late Breaking Presentation of Positive .. 
10/19Arena Pharmaceuticals, Inc. $ARNA Shares Sold by Legal & General Group Pl.. 
10/18$ARNA - Arena Pharmaceuticals, Inc. #ARNA Trading 5% Higher  
10/18Arena Pharmaceuticals, Inc. $ARNA Trading 5% Higher  
More tweets
Qtime:58
Financials ($)
Sales 2017 24,0 M
EBIT 2017 -84,2 M
Net income 2017 -90,5 M
Finance 2017 24,3 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 43,6x
EV / Sales 2018 46,8x
Capitalization 1 070 M
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | US0400471027 | 4-Traders
Technical analysis trends ARENA PHARMACEUTICALS, INC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 37,0 $
Spread / Average Target 36%
EPS Revisions
Managers
NameTitle
Amit D. Munshi President, Chief Executive Officer & Director
Tina Susan Nova Chairman
Kevin R. Lind Chief Financial Officer & Executive Vice President
John Adams Head-Scientific Affairs
Preston S. Klassen Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS, INC.14.01%1 070
INCYTE CORPORATION13.88%24 054
QUINTILES IMS HOLDINGS INC35.48%22 162
LONZA GROUP57.01%19 392
CELLTRION, INC.--.--%19 297
ALNYLAM PHARMACEUTICALS, INC.206.36%10 522